Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
- Sonneveld, P.
- Richardson, P.G.
- Ludwig, H.
- Dimopoulos, M.-A.
- Schjesvold, F.H.
- Hájek, R.
- Abdulhaq, H.
- Thuresson, M.
- Norin, S.
- Bakker, N.A.
- Mateos, M.-V.
ISSN: 2152-2669, 2152-2650
Argitalpen urtea: 2023
Alea: 23
Zenbakia: 9
Orrialdeak: 687-696
Mota: Artikulua